EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Local Specific IgE Levels Can Predict and Monitor the Therapeutic Response to Subcutaneous Immunotherapy With House Dust Mite

Xu Xu, Jingyun Li, Xu Zhang iD, Yu Song, Lin Xi, Luo Zhang iD, Yuan Zhang iD

International Forum of Allergy & Rhinology · 2026

DOI: 10.1002/alr.70098 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Forum of Allergy & Rhinology, 2026. Verfasst von Xu Xu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Allergy, Beijing Tongren Hospital, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Immunoglobulin E, Desensitization, Immunologic, Rhinitis, Allergic, Antigens, Dermatophagoides. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: the National Key R&D Program of China, Beijing Municipal Science & Technology Commission, Changjiang Scholars and Innovative Research Team.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Identifying predictive and monitoring biomarkers for allergen immunotherapy response is crucial for enhancing clinical efficacy. This study aims to investigate the systemic and local levels of immunoglobulins and identify potential biomarkers in house dust mite (HDM) allergic rhinitis (AR) patients who are undergoing subcutaneous immunotherapy (SCIT).

Methods

This study enrolled 114 AR patients who completed 1‐year SCIT follow‐up. High responders and low responders were classified based on >30% improvement in the average total combined score (ATCS). Immunoglobulin levels of HDM and its major components were measured in serum and nasal secretions before and after treatment. Predictive index (Pi) and therapeutic index (Ti) analyses were performed using linear regression to assess the impact of baseline immunoglobulin concentrations and their pre‐ to post‐treatment changes on symptom alleviation. Receiver operating characteristic (ROC) curve analysis with area under the curve (AUC) quantification was performed to evaluate predictive value for clinical responses.

Results

Positive SCIT response correlated with lower baseline age and higher symptom scores, allergen‐specific IgE (sIgE) levels, and sIgE/total IgE (tIgE) ratio. Pi analysis revealed that elevated pre‐treatment nasal sIgE levels and higher sIgE/tIgE ratios for Der p , Der f , Der p 1, and Der p 2 distinguished high from low responders. Ti analysis showed that post‐treatment decreases in these nasal sIgE levels correlated with improved clinical outcomes. Logistic regression showed baseline sIgE/tIgE ratios for Der p and Der f both in serum and nasal secretions, and Der p 1 and Der p 2 in serum positively correlated with clinical improvement. The sIgE/tIgE ratios of Der p (0.833 vs. 0.758) and Der f (0.813 vs. 0.738) in nasal secretions exhibited higher AUC values compared to serum.

Conclusions

Immunologic indicators in nasal secretions are potential biomarkers for the effective prediction and monitoring of early SCIT responses.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immunoglobulin EDesensitization, ImmunologicRhinitis, AllergicAntigens, DermatophagoidesDust Mite AllergyPyroglyphidaeHumansAnimalsFemaleMaleAdultBiomarkersAdolescentInjections, SubcutaneousTreatment OutcomeYoung AdultChildMiddle Aged

Stichwörter der Autor:innen

allergic rhinitisbiomarkerclinical responselocal immune signaturesubcutaneous immunotherapy

Substanzen

Immunoglobulin EAntigens, DermatophagoidesBiomarkers

Autor:innen und Institutionen

  • Department of Allergy, Beijing Tongren Hospital, Capital Medical University, Beijing, China.
  • Beijing Laboratory of Allergic Diseases, Beijing Municipal Education Commission and Beijing Key Laboratory of Nasal Diseases, Beijing Institute of Otolaryngology, Beijing, China.
  • Department of Otolaryngology Head and Neck Surgery, Beijing Tongren Hospital, Capital Medical University, Beijing, China.
  • Laboratory for Clinical Medicine, Capital Medical University, Beijing, China.

ORCID-Profile: Xu Zhang, Luo Zhang, Yuan Zhang

Förderung

  • the National Key R&D Program of China
  • Beijing Municipal Science & Technology Commission
  • Changjiang Scholars and Innovative Research Team
  • Natural Science Foundation of China
  • Capital's funds for health improvement and research
  • Beijing Municipal Public Welfare Development and Reform Pilot Project for Medical Research Institutes
  • National Natural Science Foundation of China

Zitieren

APA

Xu, X., Li, J., Zhang, X., Song, Y., Xi, L., Zhang, L., & Zhang, Y. (2026). Local Specific IgE Levels Can Predict and Monitor the Therapeutic Response to Subcutaneous Immunotherapy With House Dust Mite. International Forum of Allergy & Rhinology. https://doi.org/10.1002/alr.70098

Vancouver

Xu X, Li J, Zhang X, Song Y, Xi L, Zhang L, et al. Local Specific IgE Levels Can Predict and Monitor the Therapeutic Response to Subcutaneous Immunotherapy With House Dust Mite. International Forum of Allergy & Rhinology. 2026. doi:10.1002/alr.70098

BibTeX
@article{Xu2026,
  author = {Xu, Xu and Li, Jingyun and Zhang, Xu and Song, Yu and Xi, Lin and Zhang, Luo and Zhang, Yuan},
  title = {Local Specific IgE Levels Can Predict and Monitor the Therapeutic Response to Subcutaneous Immunotherapy With House Dust Mite},
  journal = {International Forum of Allergy & Rhinology},
  year = {2026},
  doi = {10.1002/alr.70098}
}
Kostenlos starten →